By Deena Beasley (Reuters) - Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their .
Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill